Chrissy Metz embraces GLP-1 drug for health improvements

In a recent interview, Chrissy Metz, the 45-year-old actor from 'This Is Us,' revealed her decision to take a GLP-1 drug after initially being skeptical. Influenced by a friend's insights and her own family's struggles with obesity, she consulted her doctors and began the treatment. Since then, Metz has experienced improvements in her mental focus, physical health, and overall well-being, emphasizing the importance of personal health choices and thorough research before starting any medication.

Chrissy Metz embraces GLP-1 drug for health improvements
1 source
Published Aug 10, 2026

Topic overview

Briefly

  • Chrissy Metz began taking a GLP-1 drug after discussing its benefits with a friend.
  • She has noticed significant mental and physical health improvements since starting the medication.
  • Metz encourages others to research and consider their health choices carefully.

What happened

In a recent interview, Chrissy Metz, the 45-year-old actor known for her role in 'This Is Us,' shared her journey with GLP-1 medication, which she began taking after careful consideration. Initially skeptical about the drug, Metz was influenced by a friend's insights into its potential health benefits, especially given her personal experiences with obesity-related issues in her family. After consulting with her doctors, she decided to proceed with the treatment, aiming to improve her overall health and well-being.

Since starting the medication, Metz has reported significant changes in her mental and physical health. One of the most notable improvements is her reduced preoccupation with food, allowing her to explore her creativity and focus on activities that benefit her long-term health. She emphasized that taking the medication is not a shortcut but requires diligence and commitment to a healthier lifestyle. Metz has also experienced physical benefits, including a regulated menstrual cycle, reduced inflammation, and improved joint health, which have led to changes in her body measurements.

Despite these positive changes, Metz is cautious about focusing on weight as a number, believing that it can lead to obsession. Instead, she is more interested in the broader spectrum of her health, including her physical strength and the variety of foods and experiences she chooses. She encourages others considering GLP-1 drugs to conduct thorough research and remain skeptical about any treatment, as individual responses can vary significantly.

Metz is aware that her choice to use medication may attract scrutiny, but she remains firm in her belief that everyone should prioritize their health in a way that feels right for them. Her journey highlights the importance of personal choice in health decisions and the need for open discussions about the benefits and challenges of using medications like GLP-1.

Comprehensive report

Full story,
in detail.

Trace the developments that led here, see how the story evolved, and understand the forces and wider context surrounding it.

Entities

How Mestios works We aggregate coverage, extract key information, and use AI to summarize and compare perspectives. Learn more

Updated Aug 10, 2026

AI-generated summary. Please verify important information from original sources.